|
1
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T,
Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, et
al: Global, regional, and national cancer incidence, mortality,
years of life lost, years lived with disability, and
disability-adjusted life-years for 29 cancer groups, 1990 to 2016:
A systematic analysis for the Global Burden of Disease Study. JAMA
Oncol. 4:1553–1568. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang
L, Huang D, Tan C, Sheng W and Du X: Plasma miR-601 and miR-760 are
novel biomarkers for the early detection of colorectal cancer. PLoS
One. 7:e443982012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanaan Z, Rai SN, Eichenberger MR, Roberts
H, Keskey B, Pan J and Galandiuk S: Plasma miR-21: A potential
diagnostic marker of colorectal cancer. Ann Surg. 256:544–551.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giráldez MD, Lozano JJ, Ramírez G, Hijona
E, Bujanda L, Castells A and Gironella M: Circulating microRNAs as
biomarkers of colorectal cancer: Results from a genome-wide
profiling and validation study. Clin Gastroenterol Hepatol.
11:681–688.e3. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hofsli E, Sjursen W, Prestvik WS, Johansen
J, Rye M, Tranø G, Wasmuth HH, Hatlevoll I and Thommesen L:
Identification of serum microRNA profiles in colon cancer. Br J
Cancer. 108:1712–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo X, Stock C, Burwinkel B and Brenner H:
Identification and evaluation of plasma microRNAs for early
detection of colorectal cancer. PLoS One. 8:e628802013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X,
Yu L, Wang L, Wang J, Wu Y, et al: A plasma microRNA panel for
early detection of colorectal cancer. Int J Cancer. 136:152–161.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aslam MI, Taylor K, Pringle JH and Jameson
JS: microRNAs are novel biomarkers of colorectal cancer. Br J Surg.
96:702–710. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell ivision. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stiegelbauer V, Perakis S, Deutsch A, Ling
H, Gerger A and Pichler M: MicroRNAs as novel predictive biomarkers
and therapeutic targets in colorectal cancer. World J
Gastroenterol. 20:11727–11735. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Zhang K, Bi M, Jiao X, Zhang D
and Dong Q: Circulating microRNA expressions in colorectal cancer
as predictors of response to chemotherapy. Anticancer Drugs.
25:346–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Molina-Pinelo S, Carnero A, Rivera F,
Estevez-Garcia P, Bozada JM, Limon ML, Benavent M, Gomez J, Pastor
MD, Chaves M, et al: MiR-107 and miR-99a-3p predict chemotherapy
response in patients with advanced colorectal cancer. BMC Cancer
Sep. 14:6562014. View Article : Google Scholar
|
|
17
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1567–1575. 2014. View Article : Google Scholar
|
|
18
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercelluar communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hannafon BN and Ding WQ: Intercelluar
communication by exosome-derived microRNAs in cancer. Int J Mol
Sci. 14:14240–14269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi
LW, Wu L, Cheng W, Zhu J, Zhang L, et al: A panel of microRNA
signature in serum for colorectal cancer diagnosis. Oncotarget.
8:17081–17091. 2017.PubMed/NCBI
|
|
22
|
Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo
RH, Cheng WF, Wang F, Qi LW, Chen Y, et al: A six-microRNA panel in
plasma was identified as a potential biomarker for lung
adenocarcinoma diagnosis. Oncotarget. 8:6513–6525. 2017.PubMed/NCBI
|
|
23
|
Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z,
Xiang Y, Wu N, Wu L, Bai L and Li Y: Circulating exosomal microRNAs
as prognostic biomarkers for non-small-cell lung cancer.
Oncotarget. 8:13048–13058. 2017.PubMed/NCBI
|
|
24
|
Tsukamoto M, Iinuma H, Yagi T, Matsuda K
and Hashiguchi Y: Circulating exosomal MicroRNA-21 as a biomarker
in each tumor stage of colorectal cancer. Oncology. 92:360–370.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takano Y, Masuda T, Iinuma H, Yamaguchi R,
Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, et al:
Circulating exosomal microRNA-203 is associated with metastasis
possibly via inducing tumor-associated macrophages in colorectal
cancer. Oncotarget. 8:78598–78613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Banzhaf-Strathmann J and Edbauer D: Good
guy or bad guy: The opposing roles of microRNA 125b in cancer. Cell
Commun Signal. 12:302014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamada A, Horimatsu T, Okugawa Y, Nishida
N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, et al: Serum
miR-21, miR-29a, and miR-125b are promising biomarkers for the
early detection of colorectal neoplasia. Clin Cancer Res.
21:4234–4242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Svoboda M, Izakovicova Holla L, Sefr R,
Vrtkova I, Kocakova I, Tichy B and Dvorak J: Micro-RNAs miR125b and
miR137 are frequently upregulated in response to capecitabine
chemoradiotherapy of rectal cancer. Int J Oncol. 33:541–547.
2008.PubMed/NCBI
|
|
30
|
D'Angelo E, Fassan M, Maretto I,
Pucciarelli S, Zanon C, Digito M, Rugge M, Nitti D and Agostini M:
Serum miR-125b is a non-invasive predictive biomarker of the
pre-operative chemoradiotherapy responsiveness in patients with
rectal adenocarcinoma. Oncotarget. 7:28647–28657. 2016.PubMed/NCBI
|
|
31
|
Tanaka H, Hazama S, Iida M, Tsunedomi R,
Takenouchi H, Nakajima M, Tokumitsu Y, Kanekiyo S, Shindo Y,
Tomochika S, et al: miR-125b-1 and miR-378a are predictive
biomarkers for the efficacy of vaccine treatment against colorectal
cancer. Cancer Sci. 108:2229–2238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hansen TF, Carlsen AL, Heegaard NH,
Sørensen FB and Jakobsen A: Changes in circulating microRNA-126
during treatment with chemotherapy and bevacizumab predicts
treatment response in patients with metastatic colorectal cancer.
Br J Cancer. 112:624–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R,
Cao Z, Singh B, Franklin JL, Wang J, Hu H, et al: lncRNA
MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance
via Wnt/β-catenin signaling. Nat Med. 23:1331–1341. 2017.
View Article : Google Scholar : PubMed/NCBI
|
